Hepatic Elimination of Drugs in Gestational Diabetes.

CONCLUSION: Considering the frequency of the disease and the effects that these pharmacokinetic changes might have on the mother and child, the need for further research seems advisable. In the meantime, cautious clinical judgment in the management of drug administration in women affected by this disease is recommended. PMID: 29577863 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29577863?dopt=Abstract

Source: Current Clinical Pharmacology - March 25, 2018 Category: Drugs & Pharmacology Authors: Gonzalez CD, Alvarinas J, Bolanos R, Di Girolamo G Tags: Curr Clin Pharmacol Source Type: research